Company Summary:. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writer™ platforms, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences inn... view job details
The Company:. Inzen Therapeutics is a privately held, early-stage biotechnology company exploring Thanokine. TM. Biology as a surprising and important driver of disease. While the ability of living cells to respond to messages from other living cells is a well-established concept, Inzen has identified that living cells also respond to messages released by cells as they undergo turnover and die. We call these messages Thanokines. TM. , and the way a cell undergoes turnover dramatically alters the Thanokines. TM. that are released. Thanokines. TM. can elicit a broad array of responses in living... view job details
Company Summary:. FL74, Inc. is a privately held, well-funded, early-stage biotechnology company that leverages advances in machine learning to fundamentally change how we innovate in science and technology. Flagship Pioneering is an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Since Flagship’s founding in 2000, the firm has originated and fostered the development of nearly 100 scientific ventures resulting in $19+ billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents. The... view job details
Company Summary:. Tessera Therapeutics is pioneering Gene Writing to cure disease. Our genome is a mosaic comprising genes that protect us from, predispose us to, and cause disease. Gene Editing biotechnologies heralded the era of genome-modifying medicines, but they cannot address most diseases. Gene Writing is a new biotechnology that writes therapeutic messages into the genome to cure thousands of diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies.... view job details
Company Summary:. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation en... view job details
About Inzen:. Inzen Therapeutics is a privately held, early-stage biotechnology company exploring Thanokine. TM. Biology as a surprising and vital driver of disease. While the ability of living cells to respond to messages from other living cells is a well-established concept, Inzen has identified that living cells also respond to messages released by cells as they undergo turnover and die. We call these messages Thanokines. TM. , and the way a cell undergoes turnover dramatically alters the Thanokines. TM. that are released. Thanokines. TM. can elicit a broad array of responses in living cel... view job details
The Company:. Inzen Therapeutics is a privately held, early-stage biotechnology company exploring Thanocrine Signaling. TM. as a surprising and important driver of disease. While communication between living cells is a well-established concept, Inzen has identified Thanocrine Signaling as a form of communication between dying and living cells. The way a cell dies matters, and we have found that this process plays an under-appreciated role in a variety of diseases. Our mission is to pioneer a novel category of drugs based on manipulating Thanocrine Signaling. TM. for the treatment of cancer, ... view job details
Company Summary:. Founded in 2017 within Flagship Labs, Cellarity’s new approach to drug discovery is based on the computational modeling of cell behavior, leading to a more complete understanding of system and network biology to uncover cell-behavior-targeted medicines for a wide variety of diseases. Cellarity recently raised $123 million in Series B financing. The round included contributions from funds and accounts managed by BlackRock, The Baupost Group, Banque Pictet on behalf of their clients and eight other investors alongside Flagship Pioneering. Cellarity is generating unprecedented b... view job details
Company Summary:. Cellarity, Inc. is a privately held, well-funded, early-stage biotechnology company that is pioneering a novel transformative therapeutic approach. Cellarity was founded by Flagship Pioneering, a team of entrepreneurial scientists that conceives, creates, resources, and grows first-in-category life sciences companies. Since 2000, Flagship has created over 75 groundbreaking companies that are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna Therapeutics (... view job details
Company Summary:. Tessera Therapeutics is pioneering Gene Writing to cure disease. Our genome is a mosaic comprising genes that protect us from, predispose us to, and cause disease. Gene Editing biotechnologies heralded the era of genome-modifying medicines, but they cannot address most diseases. Gene Writing is a new biotechnology that writes therapeutic messages into the genome to cure thousands of diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies.... view job details